Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Dung‐Tsa Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5026-415X; OpenAlex author ID A5000451156. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 3 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 13

  1. Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43856-025-01277-9↗
  2. The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1055-9965.epi-25-0237↗
  3. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of t… Co-author DOI 10.3389/fonc.2024.1362244↗
  4. A Case Control Study of the Seroprevalence of Helicobacter pylori Proteins and Their Association with Pancreatic Cancer Risk. Co-author DOI 10.1089/pancan.2021.0010↗
  5. The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pan… Co-author DOI 10.3390/cancers13040809↗
  6. Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor … Co-author DOI 10.1002/cam4.2180↗
  7. Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000580↗
  8. Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer. Co-author DOI 10.1097/rlu.0000000000001098↗
  9. Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-015-5006-1↗
  10. Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer. First author DOI 10.1097/mpa.0000000000000218↗
  11. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0133562↗
  12. Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism. Co-author DOI 10.1371/journal.pone.0052526↗
  13. SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e31823f429f↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mokenge Peter Malafa · 9 shared papers, 2012–2025 · strength 0.67
  2. José M. Pimiento · 8 shared papers, 2013–2025 · strength 0.63
  3. Jennifer B. Permuth · 4 shared papers, 2019–2025 · strength 0.55
  4. Pamela Joy Hodul · 5 shared papers, 2013–2025 · strength 0.46
  5. Daniel K. Jeong · 3 shared papers, 2019–2025 · strength 0.38
  6. Andrew R. Judge · 3 shared papers, 2019–2025 · strength 0.38
  7. Jason B. Fleming · 3 shared papers, 2019–2025 · strength 0.38
  8. Sarah M. Judge · 2 shared papers, 2025 · strength 0.31
  9. Nathan H. Parker · 2 shared papers, 2025 · strength 0.31
  10. Evan W. Davis · 2 shared papers, 2025 · strength 0.31
  11. Vic Velanovich · 2 shared papers, 2025 · strength 0.31
  12. Paul A. Stewart · 2 shared papers, 2025 · strength 0.31
  13. Margaret A. Park · 2 shared papers, 2025 · strength 0.31
  14. J. Pablo Arnoletti · 2 shared papers, 2025 · strength 0.31
  15. Jose Gilberto Trevino · 2 shared papers, 2025 · strength 0.31
  16. Sylvia L. Crowder · 2 shared papers, 2025 · strength 0.31
  17. Ghulam Rasool · 2 shared papers, 2025 · strength 0.31
  18. Ashley H. Davis-Yadley · 4 shared papers, 2015–2016 · strength 0.24
  19. Nipun B. Merchant · 2 shared papers, 2019–2025 · strength 0.22
  20. Barbara Ann Centeno · 4 shared papers, 2012–2016 · strength 0.18
  21. Anna R. Giuliano · 1 shared paper, 2021 · strength 0.17
  22. Kun Jiang · 1 shared paper, 2025 · strength 0.16
  23. Shaffer R. S. Mok · 1 shared paper, 2025 · strength 0.16
  24. for the Florida Pancreas Collaborative · 1 shared paper, 2025 · strength 0.16
  25. Dae Won Kim · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.